title: [How to do vasoreactivity test?].
authors.affiliation: Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey. dru_canpolat@yahoo.com
authors.forename: Uğur
authors.initials: U
authors.lastname: Canpolat
authors.forename: Ergün Barış
authors.initials: EB
authors.lastname: Kaya
mesh_terms: D000241:Adenosine / Q000009:adverse effects; D000280:Administration, Inhalation; D000959:Antihypertensive Agents / Q000009:adverse effects; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects; D002407:Catheterization, Swan-Ganz / Q000009:adverse effects / Q000379:methods* / Q000592:standards; D011464:Epoprostenol / Q000009:adverse effects; D006439:Hemodynamics / Q000502:physiology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis* / Q000503:physiopathology; D016285:Iloprost / Q000008:administration & dosage / Q000009:adverse effects; D009569:Nitric Oxide / Q000009:adverse effects; D011651:Pulmonary Artery / Q000503:physiopathology*; D014665:Vasodilator Agents / Q000009:adverse effects
chemical_list: D000959:Antihypertensive Agents; D001993:Bronchodilator Agents; D014665:Vasodilator Agents; D009569:Nitric Oxide; D011464:Epoprostenol; D016285:Iloprost; D000241:Adenosine